Pharmacogenomics

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmacy + genomics) reflects it’s combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets).

 

  • Drug-metabolizing enzymes
  • Predictive prescribing
  • Clinical implementation
  • Polypharmacy
  • Drug labeling

Related Conference of Pharmacogenomics

July 17-18, 2020

10th Glycobiology World Congress

Vienna, Austria
August 03-04, 2020

12th Euro Biosensors & Bioelectronics Congress

Zurich, Switzerland
September 22-23, 2020

International Conference on Nucleic Acids

Dubai, UAE
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
September 29-30, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
October 21-22, 2020

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 07-08, 2020

9th World Congress on Glycobiology & Glycochemistry

Dubai, UAE
December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
April 01-02, 2021

12th Tissue Science and Regeneration Congress

Abu Dhabi, UAE
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic

Pharmacogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in